Relations between histology, TNM-Category and results of treatment with methotrexate-bleomycin-combination in squamous cell carcinomas of the oral cavity.
D001761:Bleomycin / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002342:Carotid Artery, External; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D006801:Humans; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D008727:Methotrexate / Q000627:therapeutic use*; D009062:Mouth Neoplasms / Q000188:drug therapy*; D011379:Prognosis
D004338:Drug Combinations; D001761:Bleomycin; D008727:Methotrexate